CLASS III Drug recall · Reported 5 May 2021 · FDA Enforcement Report

Betamethasone Dipropionate Ointment USP, 05% (Augmented) recalled

Teligent Pharma is recalling Betamethasone Dipropionate Ointment USP, 05% (Augmented), distributed nationwide in the US. The recall was initiated on 2 Feb 2021 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot #: 14297, Exp 9/2021; 15372, Exp 3/2022; 15841, Exp 8/2022
Quantity recalled104,784 tubes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0338-2021
FDA event ID
87266
Recalling firm
Teligent Pharma, Buena, NJ
Classification
Class III
Status
Terminated
Recall initiated
2 Feb 2021
FDA classified
23 Apr 2021
Reported
5 May 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

2 Feb 2021Recall initiated by company
23 Apr 2021Classified by FDA+80 days
5 May 2021Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Impurities/ Degradation Specifications - OOS for know impurity Betamethasone 17- propionate.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Betamethasone Dipropionate Ointment USP, 0.05% (Augmented), packaged in 15 grams tubes, Manufactured by: Teligent Pharma, Inc. Buena, New Jersey 08310, NDC 52565-019-15

Where it was distributed

USA Nationwide

Nationwide

Questions about this recall

Is Betamethasone Dipropionate Ointment USP, 05% (Augmented) recalled?

Yes. Teligent Pharma recalled Betamethasone Dipropionate Ointment USP, 05% (Augmented) on 2 Feb 2021. The recall is Class III and its status is Terminated. Recall number D-0338-2021.

Why was it recalled?

Failed Impurities/ Degradation Specifications - OOS for know impurity Betamethasone 17- propionate.

Which lots are affected?

Lot #: 14297, Exp 9/2021; 15372, Exp 3/2022; 15841, Exp 8/2022

Where was it sold?

USA Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Teligent Pharma

All 63

Other Betamethasone dipropionate recalls

All 9